Chemoinformaics analysis of Dimethyltryptamine-N-oxide
| Molecular Weight | 204.273 | nRot | 3 |
| Heavy Atom Molecular Weight | 188.145 | nRig | 10 |
| Exact Molecular Weight | 204.126 | nRing | 2 |
| Solubility: LogS | 0.609 | nHRing | 1 |
| Solubility: LogP | 0.407 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
| nHA | 1 | APOL | 33.7107 |
| nHD | 1 | BPOL | 18.6293 |
| QED | 0.604 |
| Synth | 2.551 |
| Natural Product Likeliness | 0.58 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.998 |
| HIA | 0.906 |
| CACO-2 | -5.235 |
| MDCK | 0.0000103 |
| BBB | 0.495 |
| PPB | 0.228966 |
| VDSS | 1.769 |
| FU | 0.77151 |
| CYP1A2-inh | 0.152 |
| CYP1A2-sub | 0.967 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.907 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.086 |
| CL | 10.028 |
| T12 | 0.952 |
| hERG | 0.031 |
| Ames | 0.046 |
| ROA | 0.583 |
| SkinSen | 0.074 |
| Carcinogencity | 0.197 |
| EI | 0.789 |
| Respiratory | 0.657 |
| NR-Aromatase | 0.097 |
| Antiviral | No |
| Prediction | 0.629653 |